NeonMind Biosciences Inc: NeonMind to Present at the Benzinga Global Small Cap Conference
NeonMind Biosciences Inc: NeonMind to Present at the Benzinga Global Small Cap Conference NeonMind Biosciences Inc. ( NeonMind" or the " Company"), an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions, today announced that Robert Tessarolo, President and Chief Executive Officer, will participate in a virtual presentation at the Benzinga Global Small Cap Conference taking place from May 13-14, 2021. NeonMind to Present at the Benzinga Global Small Cap Conference To view an enhanced ver...
Source: finanznachrichten.de